Sale!

SYNE2 Gene Emery-Dreifuss muscular dystrophy type 5 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the SYNE2 gene that are associated with Emery-Dreifuss Muscular Dystrophy (EDMD) type 5. This condition is a rare form of muscular dystrophy characterized by muscle weakness and wasting, joint contractures, and heart problems, which can vary in severity among affected individuals. The genetic test involves analyzing the patient’s DNA to identify mutations in the SYNE2 gene, which play a crucial role in the structural integrity and function of muscle and heart cells. Early detection through this test can aid in the management and treatment of the condition, potentially improving the quality of life for those affected. The test is priced at 4400 AED and is conducted with high precision and confidentiality at DNA Labs UAE, ensuring patients receive accurate and timely results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test

Are you concerned about Emery-Dreifuss muscular dystrophy type 5? DNA Labs UAE offers a comprehensive genetic test to help diagnose this rare genetic disorder. Our SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test can provide valuable insights into the condition and aid in the development of effective treatment plans.

Test Components and Price

The SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test is priced at AED 4400.0. The test requires a blood sample or extracted DNA, or even just one drop of blood on an FTA card. Our expert team utilizes NGS technology to analyze the genetic material and identify any mutations in the SYNE2 gene.

Report Delivery and Method

Once the sample is collected, the report will be delivered within 3 to 4 weeks. Our advanced NGS technology ensures accurate and reliable results.

Test Type and Doctor

The SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test falls under the category of neurological disorders. It is recommended to consult a neurologist for this test, as they specialize in diagnosing and treating such conditions.

Test Department and Pre-Test Information

The SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test is conducted by our Genetics department. Before undergoing the test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5.

About Emery-Dreifuss Muscular Dystrophy Type 5

Emery-Dreifuss muscular dystrophy type 5 is a rare genetic disorder that primarily affects muscle and joint function. The SYNE2 gene is associated with this condition. Genetic testing using NGS technology can help identify any mutations in the SYNE2 gene, enabling a definitive diagnosis. This diagnosis is crucial for developing effective treatment plans and providing genetic counseling to affected individuals and their families.

Test Name SYNE2 Gene Emery-Dreifuss muscular dystrophy type 5 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SYNE2 Gene Emery-Dreifuss muscular dystrophy type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SYNE2 Gene Emery-Dreifuss muscular dystrophy type 5
Test Details

The SYNE2 gene is associated with Emery-Dreifuss muscular dystrophy type 5, a rare genetic disorder that affects muscle and joint function. NGS (next-generation sequencing) genetic testing can be used to identify mutations in the SYNE2 gene that may be responsible for the disorder. This type of testing can provide a definitive diagnosis, which can be helpful for developing treatment plans and providing genetic counseling for affected individuals and their families.